PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- UROXATRAL
- Generic name / active ingredient
- alfuzosin hydrochloride extended-release tablets
- Dosage-form class
- Alfuzosin hydrochloride 10 mg oral extended-release tablet: a round three-layer tablet with one white layer between two yellow layers, debossed X10. The current label says to swallow it whole and not crush, split or chew it.
- Route
- Oral
- Record reviewed
- 2026-09-02
Copy from the pack in hand
Source-linked reading points
- This is a three-layer extended-release tablet. Do not split, crush or chew it because of swallowing difficulty, a desired reduction or its layered appearance; have a pharmacist review the actual pack and current label for handling or another suitable form.
- The label warns about postural hypotension, dizziness and syncope and notes potentially increased risk with antihypertensive medicines or nitrates. Older adults, people with falls or several cardiovascular medicines should prioritise full-list, blood-pressure and exact-pack review with a clinician or pharmacist; do not self-separate or stop a pack.
- The label contraindicates potent CYP3A4 inhibitors such as ketoconazole, itraconazole and ritonavir and warns that PDE5 inhibitors such as sildenafil or tadalafil can increase symptomatic-hypotension risk. The site provides no self-directed spacing, halving or temporary-stop plan.
- Before cataract surgery or another eye procedure, tell the eye team about current or previous UROXATRAL/other alpha-blocker use. The label does not support self-stopping for this reason.
Reviewed presentation examples — compare every field
- Alfuzosin hydrochloride 10 mg per tablet; 30-tablet child-resistant bottleNDC 59212-200-30
- Alfuzosin hydrochloride 10 mg per tablet; 100-tablet child-resistant bottleNDC 59212-200-10